In Table 3, we present a comprehensive list of key topics and questions that warrant further investigation, which will ultimately contribute to a more in-depth understanding of Galectin-3’s roles and its potential as a therapeutic target in the context of viral infections. This evidence concerns the gene LGALS3 and viral infectious disease.